As of Wednesday close, Eyenovia Inc.’s (NASDAQ:EYEN) stock was up $0.1, moving up 5.59 percent to $1.89. The average number of shares traded per day over the past five days has been 122,660 shares. 3 times new highs have been achieved over the past 5 days, with a $0.0700 gain in that time frame. In the last twenty days, the average volume was 187,375, while in the previous 50 days, it was 250,942.
Since last month, EYEN stock retreated -12.90%. Shares of the company fell to $1.6900 on 11/15/22, the lowest level in the past month. A 52-week high of $4.21 was reached on 01/03/22 after having rallying from a 52-week low of $1.52. Since the beginning of this year, EYEN’s stock price has dropped by -52.75% or -$2.1100, and marked a new high 1 time. However, the stock has declined by -55.11% since its 52-week high.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
EYEN stock investors should be aware that Eyenovia Inc. (EYEN) stock had its last reported insider trading activity 85 days ago on Aug 31. Strahlman Ellen R, the Director of the company, purchased of 6,686 shares for $1.62 on Aug 31. It resulted in a $10,805 investment by the insider. Strahlman Ellen R added 6,744 shares at an average price of $1.60 on Aug 30. The insider now owns 36,366 shares following the transaction. On Aug 29, Director Strahlman Ellen R bought 7,931 shares at $1.62 apiece. The transaction was valued at $12,838.
The stock’s beta is 1.59. Besides these, the trailing price-to-sales (P/S) ratio of 6.83, the price-to-book (PB) ratio of 3.30.
In the three months ended September 29, Eyenovia Inc.’s quick ratio stood at 2.70, while its current ratio was 2.70, showing that the company is able to pay off its debt. Based on annual data, EYEN earned $12.4 million in gross profit and brought in $14.0 million in revenue.
While analysts expected Eyenovia Inc. to report -$0.2 quarterly earnings, the actual figure was -$0.21 per share, beating the consensus estimate by -5.00%. During the quarter, the company generated -$7.12 million in EBITDA. The liabilities of Eyenovia Inc. were 11.08 million at the end of its most recent quarter ended September 29, and its total debt was $7.23 million. The value of shareholders’ equity is $36.11 million.
This quick technical analysis looks at Eyenovia Inc.’s (EYEN) price momentum. With a historical volatility rate of 44.24%, the RSI 9-day stood at 49.74% on 23 November.
With respect to its five-day moving average, the current Eyenovia Inc. price is up by +3.85% percent or $0.0700. At present, EYEN shares trade -18.88% below its 20-day simple moving average and +3.85% percent above its 100-day simple moving average. However, the stock is currently trading approximately -22.86% below its SMA50 and -38.83% below its SMA200.
Stochastic coefficient K was 30.94% and Stochastic coefficient D was 22.45%, while ATR was 0.1368. Given the Stochastic reading of 46.51% for the 14-day period, the RSI (14) reading has been calculated as 46.06%. As of today, the MACD Oscillator reading stands at 0.0133, while the 14-day reading stands at -0.0102.
Northland Capital launched its rating on Eyenovia Inc. (NASDAQ: EYEN) to an Outperform in a note to investors on March 01, 2021. Eyenovia Inc. (EYEN) has been rated Buy by analysts. According to 0 brokerage firms, EYEN is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Eyenovia Inc. stock as buy, with 2 recommending it as overweight.
With a median target price of $13.50, the current consensus forecast for the stock is $12.00 – $15.00. Based on these forecasts, analysts predict Eyenovia Inc. (EYEN) will achieve an average price target of $13.50.